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Abstract
Background: Recently, developing countries have shown a dramatic increase in non-communicable diseases (NCDs).  The 
burden of  NCDs in South Africa has increased over the past years resulting in an estimated 37% of  all- cause mortality and 
16% of  disability-adjusted life years. Currently, diabetes mellitus (DM) and hypertension (HTN) are the two most prevalent 
NCDs associated with the rapid increase in mortality. 
Objective: To demonstrate the socio-demographic and modifiable risk factors of  diabetes mellitus (DM) and hypertension 
(HTN) among South African adults. 
Methods: A cross-sectional analytical study was conducted in the Cecilia Makiwane Hospital serving the residents of  
Mdantsane. Relevant socio-demographic data, anthropometric measurements, triplicate blood pressure, fasting blood glu-
cose and lipogram analysis were obtained from 265 outpatients. 
Results: Multivariate anlysis shows that; salt intake, smoking, elevated triglycerides and decreased high-density lipoprotein 
levels were significantly associated with DM with adjusted odds ratio of  0.18 (p=0.002), 0.26 (p=0.048), 2.19 (p=0.006) and 
0.38 (p=0.001), respectively. Overweight and obesity were significantly associated with hypertension with odds ratio of  0.03 
(p=0.01) and 0.06 (p=0.006), respectively. 
Conclusion: The burden of  DM and HTN on society can be drastically reduced with simple lifestyle changes, development 
of  preventative strategies, large-scale screening and better disease management in South Africa.
Keywords: Diabetes, hypertension, rural areas, Mdantsane Township,  South Africa.
DOI: https://dx.doi.org/10.4314/ahs.v20i3.41
Cite as: Xhakaza L, Abrahams-October Z, Mohammednur MM, Pearce B, Adeniyi OV, Johnson R, et al. Socio-demographic and 
modifiable risk factors of  diabetes and hypertension among resource constrained patients from rural areas in Mdantsane Township in 
South Africa. Afri Health Sci. 2020;20(3): 1344-1354. https://dx.doi.org/10.4314/ahs.v20i3.41
Corresponding author:
Mongi Benjeddou,
Precision Medicine Unit, Department of  
Biotechnology, Faculty of  Natural Sciences, 
University of  the Western Cape, Robert Sobukwe 
Road, Bellville, 7535, South Africa.
Tel: (+27)21 959 2080
Email: mbenjeddou@uwc.ac.za
Introduction
Non-Communicable Diseases (NCDs) have currently 
been identified as the leading cause of  death world-
wide.  In the past decade developing countries have 
shown a dramatic increase in NCDs 1, 2.  The burden 
of  NCDs in South Afica has increased over the past 
years resulted in an estimated 37% of  all cause mortality 
and 16% of  disability-adjusted life years 3-5.  Currently, 
Diabetes Mellitus (DM) and hypertension (HTN) are 
the two most prevalent NCDs associated with the rapid 
increase in mortality 6-10. 
DM is defined as a chronic health condition associat-
ed with elevated blood sugar levels 11; 12, whilst HTN is 
characterized by a systolic blood pressure ≥ 140 mmHg 
and a diastolic blood pressure ≥ 90 mmHg 2.  DM of-
ten co-exists with HTN since they both share com-
mon disease mechanisms and, in some instances, the 
one condition exacerbates the other 13.  Currently, 425 
million people are diagnosed with diabetes, whilst it is 
estimated that over a billion people worldwide are af-
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fected with HTN 2, 14.  Both diseases have strongly been 
associated with an increased risk of  kidney failure, obe-
sity, stroke, blindness, nerve damage and cardiovascular 
disease (CVD) 2, 15-18. 
DM and HTN have been shown to have a major impact 
on public health funding consuming a significant pro-
portion of  public health spending 7.  However, these are 
described as lifestyle diseases, thus they can be prevent-
ed or managed by drugs and lifestyle modification19-21. 
Modifiable risk factors associated with DM and HTN 
include: tobacco use, alcohol consumption, physical 
activity and unhealthy diets 22. An unhealthy diet is de-
fined, according to Forouzanfar et al 22, as a diet which 
is high in sodium, low in vegetables, low in fruit, low in 
whole grains, low in nuts and seeds, and low in seafood 
omega-3. Low- and middle-income countries are the 
most affected by these risk factors 23, 24.
The African region has been identified to have the high-
est burden of  DM and HTN 30; 14.  In Africa, DM is esti-
mated at 15.5 million adults aged between 20-79 years31 
and HTN is estimated at 46% in adults >25 years 30. 
The ever-increasing numbers of  individuals diagnosed 
with these diseases are of  great concern across the 
world especially in middle- and low-income countries 30. 
The present study highlights the burden and associated 
risk factors of  DM and HTN in Mdantsane, a resource 
constrained township of  South Africa. 
In South Africa, the burden of  NCDs is predicted to in-
crease substantially in the next decades if  the necessary 
preventative measures are not taken 25.  Furthermore, 
strategies need to be implemented to effectively man-
age these diseases 26.  Currently, there are limited studies 
exploring the prevalence and risk factors of  DM and 
HTN in South Africa, especially within the economical-
ly disadvantaged population. The aim of  this study was 
to investigate the socio-demographic and modifiable 
risk factors of  diabetes and hypertension in one of  the 
rural areas in South Africa, with resource constrained 
patients. Modifiable risk factors found significantly as-
sociated with diabetes and/or hypertension could be 




Study area and design
A cross-sectional descriptive study was conducted in 
the Cecilia Makiwane Hospital (Mdantsane, South Af-
rica) from July 2017 – October 2017.  Mdantsane is lo-
cated in the Buffalo Municipality and is a low-income 
residential township with a population of  approximate-
ly 150000 27.  The objectives of  the study were explained 
to all participants and each participant signed a consent 
form indicating voluntary participation in the study. 
Information sheets were provided in both English and 
IsiXhosa languages.  Prior to sampling, participants un-
derwent physical examination and medical history was 
recorded.
Study population and sampling
Inclusion criteria for participants in this study were in-
dividuals aged ≥18 years and have been diagnosed with 
hypertension and/or diabetes for more than a year prior 
to the study. Exclusion criteria included pregnant wom-
en, patients diagnosed with type 1 diabetes and acute 
illnesses.  Age, sex, monthly income, level of  education, 
lifestyle profile (i.e. physical activity, smoking status, al-
cohol and diet), and family history of  disease preva-
lence were obtained through interview from all of  the 
participants.  The use of  anti-hypertensive and antidia-
betic medications along with the durations of  disease(s) 
was obtained from the patients’ medical records.  Eligi-
ble participants (N=265) were recruited sequentially at 
the study setting over the study period.
Data collection
A trained research nurse conducted anthropometric 
measurements of: weight to the nearest 0.1 kg, height 
to the nearest of  0.1 cm using a stadiometer, waist cir-
cumference, hip circumference and upper-arm circum-
ference was measured using a tape measure.  Measure-
ments were taken with all participants wearing minimal 
clothing and no shoes.  Blood pressure (BP) was meas-
ured using a validated automated digital blood pressure 
monitor (Microlife® BP A100 Plus).  BP was record-
ed in triplicate and the average was used for analysis. 
Blood glucose was measured using Accutrend ® test 
strips.  Body Mass Index (BMI) for each patient was 
calculated as weight (kg) divided by height (m2) and 
was categorised based on WHO criteria: underweight 
(<18.5 kg/m2), normal weight (18.5-24.9 kg/ m2), over-
weight (25.0-29.9 kg/ m2) and obese (30 or greater kg/ 
m2).  Patients with systolic BP (SBP) of  ≥ 140 mmHg 
and ≥ 90 diastolic BP (DBP) were identified as hyper-
tensive and patients with systolic and diastolic BP below 
140 mmHg and 90 mmHg respectively were identified 
as normotensive.   
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Laboratory assessment
Fasting venous blood was obtained for all patients. 
The lipid profile which includes: total cholesterol (TC), 
triglycerides (TG), low-density lipoprotein (LDL) 
and high-density lipoprotein (HDL) for each partic-
ipant was categorized according to the guidelines of  
the Heart and Stroke Foundation of  South Africa 5, 
28.  In addition to this, the glycosylated haemoglobin 
(HbA1c) was assayed from blood samples of  diabetic 
participants 29.  All blood samples were sent to the clin-
ical laboratory centre, i.e. National Health Laboratory 
Services (NHLS) of  Cecilia Makiwane hospital and the 
East London private hospital.
Statistical analysis
Statistical analysis was performed using Statistical Pack-
age for Social Science (SPSS) version 25 for Windows 
(SPSS Inc., Chicago, IL, USA).  The clinical laboratory 
data and anthropometric measurements were expressed 
as mean (n) ± standard deviation (SD).  Differences be-
tween groups were assessed using chi-square test for 
statistical significance.  Risk factors associated with DM 
and HTN are presented as percentages with the odds 
ratios (ORs) and 95% confidence intervals (CIs).  The 
p-value ≤0.05 were considered statistically significant.
Results
In the study cohort, a total of  265 outpatients (of  
which n=175 were female and n=90 were male) were 
interviewed during a 3-month study (Table 1).  The 
mean ages of  men and women were 59.96±11.19 and 
61.32±11.60 years, respectively.  Other demographic, 
anthropometric and clinical laboratory measurements 
of  the study participants are indicated in (Table 1).
 
Table 1: Characteristics of the study subjects in Mdantsane,  

































BMI – Body Mass Index, HbA1c - glycated haemoglobin, FBG-Fasting blood glucose, TC – Total Cholesterol, HDL – high-density lipoproteins, LDL – Low Density  
Lipoproteins, TG – Triglycerides, CRT – Creatinine, GFR -  glomerular filtration rate. n – Total number of samples/patients, P-value > 0.05. * HbA1c and RBG were  
only measured for patients diagnosed with DM thus n vary. Values are presented as means ± standard deviation 
Parameter Female (n=175) Male (n=90) Total (n=265) 
Age (years) 59.96±11.19 61.32±11.6 60.42±11.32 
Weight (Kg) 87.45±21.46 81.62±16.06 85.46±19.94 
Height (cm) 159.93±6.22 168.10±11.66 162.72±9.30 
BMI (Kg/m2) 34.18±8.27 29.77±12.93 32.68±10.29 











pressure (mmHg) 155.67±20.53 157.04±21.65 156.14±20.88 
Diastolic blood 
pressure (mmHg) 92.56±13.18 93.87±13.45 93.00±13.26 
Heart rate (pbm) 84.14±13.60 80.01±14.43 82.74±13.99 
TC (mmol/L) 5.02±1.27 4.53±1.14 4.86±1.25 
HDL (mmol/L) 1.30±0.36 1.35±0.44 1.31±0.39 
LDL (mmol/L) 2.63±1.14 2.35±0.98 2.54±1.09 
TG (mmo/L) 1.71±1.01 1.88±1.06 1.77±1.03 
Table 2 and 3 indicates the socio-demographic and 
modifiable risk factors of  non-diabetic and diabetic 
groups as well as among non-hypertensive and hyper-
tensive groups. It is important to note that approxi-
mately 40% of  the study cohort was co-morbid. In 
both NCDs, the proportion of  females is higher than 
males, however, sex was only shown to be significantly 
associated amongst diabetic patients (p-value = 0.043). 
Amongst diabetic patients, smoking status; salt intake, 
TG and HDL were all significantly associated with dis-
ease incidence with p-values of  0.015; 0.004, 0.012 and 
0.003 respectively (Table 2).  All other factors, i.e. age, 
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educational level, physical activity, alcohol consump-
tion, TC and LDL were not significantly associated with 
DM (Table 2).  BMI was the only modifiable risk factor 
that showed significant association amongst hyperten-
sive patients with a p-value of  <0.0001 (Table 3). Fac-
tors not significantly associated with HTN were: sex, 
age, educational level, smoking status, physical activity, 
salt intake, and alcohol consumption, TC, TG, LDL and 
HDL (Table 3).







X2,P Value Non-diabetic Diabetic 
n = 148 % n=117 % 
Gender Male 58 64.4 32 35.5  4.08, 0.040 Female 90 51.4 85 48.6 
Age Less than 50 years 28 63.6 16 36.4  1.30, 0.260 More than 50 years 120 54.3 101 45.7 
Educational 
level 
No formal education 12 60.0 8 40.0 
 
4.78, 0.190 
Primary education 34 54.0 29 46.0 
Secondary education 97 58.1 70 41.9 
Higher education 4 28.6 10 71.4 
Smoking 
status 
Never smoked 99 52.1 91 47.9 
 
8.45, 0.015 Quit smoking 29 56.9 22 43.1 
Current smoker 20 83.3 4 16.7 
Physical 
activity 
More than 3 times / 
week 8 50.0 8 50.0  
0.25, 0.880 1-2 times/ week 119 54.6 92 43.4 
No physical activities 21 55.3 17 44.7 
Salt intake 
No salt intake 11 37.9 18 62.1  
11.15, 0.004 
 
Normal salt intake 103 53.9 88 46.1 
Increased salt intake 34 75.6 11 24.4 
Alcohol 
consumption 
Never drank 78 54.9 64 45.1 
3.63, 0.160 
 Quit drinking 40 50.6 39 49.4 
Occasional drinker 30 68.2 14 31.8 
BMI 
(Kg/m2) 




18.5-24.9 21 55.3 17 44.7 
25.0-29.9 37 53.6 32 46.4 
≥30 86 57.3 64 42.7 
TC 
(mmol/L) 
Increased 52 46.8 59 53.2  
0.15, 0.700 Normal 96 56.8 58 43.2 
TG 
(mmol/L) 
Increased 52 46.3 59 53.7  
6.28, 0.012 Normal 95 62.3 58 37.7 
HDL 
(mmol/L) 
Decreased 74 67.3 36 32.7  
8.81, 0.003 Normal 69 48.6 73 51.4 
LDL 
(mmol/L) 
Increased 50 56.8 38 43.2  
0.05, 0.820 Normal 98 55.4 79 44.6 
 
TC= Total Cholesterol, TG= Triglyceride, HDL= High density lipoprotein, LDL= Low density lipoprotein, 
mmol= mill mole, L= litre. Location: Mdantsane, Eastern Cape (July 2018) 
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X2, P value 
 
Non-hypertensive Hypertensive  
n = 13 % n= 252 %  
Gender Male 6 6.6 84 93.3 0.91, 0.34 
  
 
Female 7 4 168 96  
Age Less than 50 years 4 9.1 40 90.9 1.98, 0.16 
  
 
More than 50 years 9 4.1 212 95.9  
Educational 
level 





Primary 4 6.3 59 93.7  
Secondary 8 4.8 159 95.2  
High education 1 7.1 13 92.9  
Smoking 
status 
Never smokers 8 4.2 182 95.8 
  
1.17, 0.56 
Quit smokers 4 7.8 47 92.2 
Current smokers 1 4.2 23 95.8 
Physical 
activity 
More than 3 times / 
week 0 11.1 16 88.9   
0.88, 0.64 1-2 times/ week 11 4.3 200 95.7 
No physical activities 2 5.3 36 94.7 
Salt intake No salt intake 0 0 29 100 
  
1.84, 0.40 
Normal salt intake 10 5.2 181 94.8 
Increased salt intake 3 6.7 42 93.3 
Alcohol 
consumption 
Never drank 4 2.8 138 97.2 3.32, 0.19  
  
  
Quit drinking 5 6.3 74 93.7 
Occasional drinker 4 9.1 40 90.9 




18.5-24.9 6 15.8 32 84.2 
25.0-29.9 1 1.4 68 98.6 
≥30 4 2.7 146 97.3 
TC (mmol/L) Increased 5 4.9 98 95.1   
0.001,  0.98 Normal 8 4.9 154 95.1 
TG (mmol/L) Increased 4 3.5 107 96.5   
0.69, 0.41 Normal 9 5.8 145 94.2 
HDL (mmol/L) Decreased 2 1.8 108 98.2   
2.37, 0.12 Normal 8 5.6 134 94.4 
LDL (mmol/L) Increased 4 4.5 84 95.5   
0.04, 0.85 Normal 9 5.1 168 94.9 
        
TC= Total Cholesterol, TG= Triglyceride, HDL= High density lipoprotein, LDL= Low density lipoprotein, mmol= mill 
mole, L= litre. Location: Mdantsane, Eastern Cape (July 2018) 
Table 4 and 5 describe the univariate and multivariate 
analyses for diabetes and hypertension.  The univari-
ate results show a risk association between diabetes and 
smoking status, salt intake, TG and HDL (Table 4). The 
results gave an indication that smoking status has an im-
pact on diabetes using never smoked as the reference, 
those who quit smoking had significantly lesser odds 
(p-value = 0.824) of  diabetes in comparison to those 
who are currently smokers (p-value = 0.048) (Table 4). 
Furthermore, an increased salt intake, increased TG 
and a decreased HDL-C also demonstrated significant-
ly higher odds (p-value = 0.01) of  diabetes.  Gender 
was not significantly associated with diabetes (p-value 
= 0.210).  In table 5, an increased BMI in comparison 
to the underweight (as per WHO standards) has high-
er odds of  hypertension (p-value=0.012 and p-val-
ue=0.006).  In addition to this, participants who have 
normal BMI have lower odds of  hypertension (p-value 
= 0.420).
Multivariate logistic regression analysis showed that af-
ter adjusting for all significant factors, an increased salt 
intake and BMI were significantly associated with DM 
and HTN respectively (Table 4 and 5).
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Table 4: Univariate and Multivariate analysis for risk factors of Diabetes status 
 
  







odds ratio   P-value 
Sex 
Male 32 (35.6) 58 (64.4) 1 1   





intake 18 (62.1) 11 (37.9) 1 
1 0.009 
Normal salt 












Never smoke 91 (47.9) 99 (52.1) 1 1   










Normal level 58 (37.7) 96 (62.3) 1 1   
Increased 






Normal level 73 (51.4) 69 (48.6) 1 1   
Decreased 






Location: Mdantsane, Eastern Cape (July 2018) 
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Table 5: Univariate and Multivariate analysis for risk factors of hypertension 
 
  












<18.5 5 (71.4) 2 (28.6) 1 1   


















182 (95.8) 8 (4.2) 1 1   
Quit 
smoking 

















138 (97.2) 4 (2.8) 1 1   
Quit 
drinking 













Location: Mdantsane, Eastern Cape (July 2018) 
Discussion
South Africa has been reported to have the highest in-
cidence of  DM in the African continent 14.  Amongst 
the modifiable risk factors, significant association was 
shown with tobacco intake, increased salt intake, TG 
and HDL.  Tobacco smoking is well established as a 
risk factor for multiple diseases and has been associat-
ed with DM in multiple cohort studies 32-34.  The pres-
ent study showed that smoking was associated with the 
probability of  developing DM.  This finding is consist-
ent with previous studies conducted in Korea 35; 36.  Cur-
rent smokers and ex-smokers display a greater proba-
bility of  developing DM than non-smokers, however 
in this study, the increased risk of  ex-smokers were not 
statistically significant.  Previous studies conducted by 
Jee et al. 35 and Hur et al. 37 also reported the increased 
risk of  ex-smokers as insignificant. 
The WHO (2016) recommends that patients with DM 
should reduce their dietary salt intake 2.  The precise 
relationship between dietary salt intake and DM is not 
well defined, however, excessive salt intake is well as-
sociated with hypertension and CVDs.  In the present 
study, an increased salt intake was significantly associat-
ed with the higher incidence of  DM.  Previous studies 
also demonstrated an association between high dietary 
salt intake and DM 38-40.  Increased TG levels have been 
associated with an increased risk of  DM 41-44 and in this 
study cohort, similar results were observed.
In addition, this study also found that the odds of  hav-
ing DM were increased with a decrease in HDL.  Similar 
findings have been reported in African 45-48, European 
49 and United States communities 50; 51. Lower levels of  
HDL concentrations have been associated with many 
diseases such as CVDs 52-55, nephropathy 56 and coronary 
heart disease 57; 58.  Although, levels of  TC and LDL in 
diabetic individuals are reportedly comparable with that 
found in non-diabetics, low levels of  HDL and elevated 
TG have been reported in T2DM patients as the prob-
able cause of  CVD 52-54.  It has also been observed that 
HDL alone might not be a good indicator of  increase 
DM risk since most of  the subjects had lower total cho-
lesterol.  Moreover, lower levels of  HDL in the present 
study might be because of  the lower cholesterol.
A high BMI is a risk factor that is often associated with 
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DM 59, however, in this study; it was significantly associ-
ated with HTN, since DM and HTN co-exist in approx-
imately 40% of  the study cohort, this could be an expla-
nation for this observation.  Furthermore, many studies 
suggest that a high BMI contributes to hypertension 
60-64.  It is well established that smoking increases the 
risk of  hypertension; however, the significance of  this 
association may differ between populations 65.  In this 
study, no significant association was observed between 
hypertension and smoking status.  These findings are 
contrary to other studies 66-69. 
The following limitations need to be considered; the 
cross-sectional design and recruitment of  participants 
from one study centre might limit the generalisation of  
the findings. In addition, the scope of  this study needs 
more samples drawn from broader population across 
the country to conclude on an association that exists 
between DM and HTN with the discussed variables.  
 
Conclusion
DM was associated with smoking and salt intake; whilst 
hypertension was associated with increasing BMI.  De-
velopment of  best practices for affordable and effec-
tive programs in screening, prevention, detection and 
treatment of  DM and HTN is essential.  In order to re-
duce the burden of  NCDs, comprehensive intervention 
strategies should be implemented across the country. 
Future studies with larger sample size should be done 
to identify or generate local modifiable risk factors for 
the development of  DM and HTN.
 
Acknowledgments
The authors would also like to thank the study partici-
pants, Cecilia Makiwane Hospital and the Department 
of  Health Eastern Cape. The work reported herein was 
made possible through funding by the South African 
Medical Research Council through its Division of  Re-
search Capacity Development under funding received 
from the South African National Treasury. The content 
hereof  is the sole responsibility of  the authors and do 
not necessarily represent the official views of  the SAM-
RC or the funders. In addition, partial funding from the 
National Research Foundation of  South African was 
used for this study.
Ethical clearance
Ethical approval for this study was approved by the eth-
ics committees of  the University of  the Western Cape 
(UWC) and the Eastern Cape Department of  Health 
(Ethics Reference Number: BM/16/5/19).
Declaration of  authorship 
MB, LX, BP, OVA, RJ conceived and designed the study; 
LX acquired and prepared the data; LX and MMM an-
alysed and interpreted the data; LX and ZAO drafted 
the manuscript; LX, ZAO and MMM revised the man-
uscript for important intellectual content; all authors 
gave approval of  the version to be submitted and agree 
to be accountable for all aspects of  the work.
Competing interests 
All authors have completed the Unified Competing 
Interest form at www.icmje.org/coi_disclosure.pdf  
(available on request from the corresponding author) 
and declare: no support from any organization for the 
submitted work; no financial relationships with any or-
ganizations that might have an interest in the submitted 
work in the previous 3 years; no other relationships or 
activities that could appear to have influenced the sub-
mitted work.
References
1. van de Vijver S, Akinyi H, Oti S, Olajide A, Agyemang 
C, Aboderin I, et al. Status report on hypertension in 
Africa-Consultative review for the 6th Session of  the 
African Union Conference of  Ministers of  Health on 
NCD’s. Pan African Medical Journal. 2014; 16(1).
2. World Health Organization Global report on diabe-
tes: World Health Organization. 2016.
3. Alberts M, Urdal P, Steyn K, Stensvold I, Tverdal A, 
Nel JH, Steyn NP. Prevalence of  cardiovascular diseas-
es and associated risk factors in a rural black population 
of  South Africa. European Journal of  Cardiovascular Preven-
tion & Rehabilitation. 2005 Aug; 12(4):347-54.
4. Puoane T, Tsolekile L, Caldbick S, Igumbor E, 
Meghnath K, Sanders D. Chronic non-communicable 
diseases in South Africa: Progress and challenges. South 
African Health Review.  2012; 13:115-126.
5. Maimela E, Alberts M, Modjadji SE, Choma SS, 
Dikotope SA, Ntuli TS, Van Geertruyden J. The prev-
alence and determinants of  chronic non-communica-
ble disease risk factors amongst adults in the Dikgale 
health demographic and surveillance system (HDSS) 
site, Limpopo Province of  South Africa. PloS one. 2016; 
11(2): e0147926.
6. World Health Organization Global status report 
on noncommunicable diseases. Geneva: 2010. World 
Health Organization: 2015.
African Health Sciences Vol 20 Issue 3, September, 20201351
7. Kearney PM, Whelton M, Reynolds K, Muntner P, 
Whelton PK, He J. Global burden of  hypertension: 
analysis of  worldwide data. The Lancet. 2005 Jan 15; 
365(9455):217-23.
8. Opie LH, Seedat YK. Hypertension in sub-Sa-
haran African populations. Circulation. 2005 Dec 6; 
112(23):3562-8.
9. Centers for Disease Control and Prevention (CDC. 
Vital signs: awareness and treatment of  uncontrolled 
hypertension among adults--United States, 2003-2010. 
MMWR. Morbidity and Mmortality Weekly Report. 2012 
Sep 7; 61:703.
10. World Health Organization. World health statistics 
2012 report. World Health Organization. Geneva 2012
11. American Diabetes Association. Standards of  med-
ical care in diabetes—2014. Diabetes Care. 2014 Jan 1; 37 
Suppl 1:S14-80.
12. Pradeep T, Haranath C. A Review on Diabetes Mel-
litus Type II. International Journal of  Pharma Research & 
Review. 2014 Sep; 3(9):23-9.
13. Dokunmu TM, Yakubu OF, Adebayo AH, Olase-
hinde G.I, Chinedu SN. Cardiovascular Risk Factors in 
a Suburban Community in Nigeria. International Journal 
of  Hypertension. 2018; 2018.
14. Atlas ID. 2016. International Diabetes Federation 
7th Edition, 2015,.
15. Todd JN, Florez JC. An update on the pharmacog-
enomics of  metformin: progress, problems and poten-
tial. Pharmacogenomics. 2014 Mar; 15(4):529-39.
16. Williams B. Insulin resistance: the shape of  things to 
come. The Lancet. 1994 Aug 20; 344(8921):521-4.
17. World Health Organization. Global action plan for 
the prevention and control of  noncommunicable dis-
eases 2013-2020. 2013. Geneva: World Health Organi-
zation. 2015.
18. World Health Organization & International Socie-
ty of  Hypertension Writing Group. 2003 World Health 
Organization (WHO)/International Society of  Hyper-
tension (ISH) statement on management of  hyperten-
sion. Journal of  Hypertension. 2003; 21(11): 1983-1992.
19. Diabetes Prevention Program Research Group. Re-
duction in the incidence of  type 2 diabetes with lifestyle 
intervention or metformin. New England Journal of  Med-
icine. 2002 Feb 7; 346(6):393-403.
20. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, 
Rutten GE, Sandbæk A, Sharp SJ, Simmons RK, Van 
den Donk M, Wareham NJ, Lauritzen T. Effect of  early 
intensive multifactorial therapy on 5-year cardiovascular 
outcomes in individuals with type 2 diabetes detected by 
screening (ADDITION-Europe): a cluster-randomised 
trial. The Lancet. 2011 Jul 9; 378(9786):156-67.
21. Herman WH, Ye W, Griffin SJ, Simmons RK, 
Davies MJ, Khunti K, Rutten GE, Sandbaek A, Lau-
ritzen T, Borch-Johnsen K, Brown MB. Early detection 
and treatment of  type 2 diabetes reduce cardiovascular 
morbidity and mortality: a simulation of  the results of  
the Anglo-Danish-Dutch Study of  Intensive Treatment 
in People With Screen-Detected Diabetes in Primary 
Care (ADDITION-Europe). Diabetes Care. 2015 May 
15:dc142459.
22. Forouzanfar MH, Afshin A, Alexander LT, Ander-
son HR, Bhutta ZA, Biryukov S, Brauer M, Burnett R, 
Cercy K, Charlson FJ, Cohen AJ. Global, regional, and 
national comparative risk assessment of  79 behaviour-
al, environmental and occupational, and metabolic risks 
or clusters of  risks, 1990–2015: a systematic analysis for 
the Global Burden of  Disease Study 2015. The Lancet. 
2016 Oct 8; 388(10053):1659-1724.
23. Adeniyi OV, Yogeswaran P, Longo-Mbenza B, Ter 
Goon D. Uncontrolled hypertension and its determi-
nants in patients with concomitant type 2 diabetes mel-
litus (T2DM) in rural South Africa. PLoS One. 2016 Mar 
1; 11(3):e0150033.
24. World Health Organization & World Health Organ-
ization. Burden: mortality, morbidity and risk factors. 
Global Status Report on Non-communicable Disease.  2010; 
2011.
25. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Toll-
man SM, Bradshaw D. The burden of  non-communi-
cable diseases in South Africa. The Lancet. 2009 Sep 12; 
374(9693):934-47.
26. Ntuli ST, Alberts M, Choma S, Dikotope S, Maimela 
E. Prevalence and associated risk factors of  hyperten-
sion amongst adults in a rural community of  Limpopo 
Province, South Africa. African Journal of  Primary Health 
Care and Family Medicine. 2015; 7(1): 1-5.
27. Stats S. Statistics South Africa. Formal census. 2011
28. The Heart and Stroke Foundation, South Africa. 
The Heart and Stroke Foundation, South Africa 2017. 
Updated November 2018; cited 19 June 2018. Available 
from: http://www.heartfoundation.co.za/cholesterol/.
29. Amod A. The 2012 SEMDSA guideline for the 
management of  type 2 diabetes. Journal of  Endocrinol-
ogy, Metabolism and Diabetes in South Africa. 2012 Jan 1; 
17(1):61-2.
30. World Health Organization. World health statistics 
2015. World Health Organization. 2015
31. Atlas ID. International Diabetes Federation 8th Edi-
tion, 2017. 2017
32. US Department of  Health and Human Services. 
The health consequences of  smoking: a report of  the 
Surgeon General, 2004.
African Health Sciences Vol 20 Issue 3, September, 2020 1352
33. Willi C, Bodenmann P, Ghali WA, Faris PD, Cor-
nuz J. Active smoking and the risk of  type 2 diabetes: 
a systematic review and meta-analysis. JAMA. 2007; 
298(22): 2654-2664.
34. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obe-
sity and Body Fat Distribution in Relation to the In-
cidence of  Non-lnsulin-dependent Diabetes Mellitus: 
A Prospective Cohort Study of  Men in the Norma-
tive Aging Study. American Journal of  Epidemiology. 1992; 
136(12): 1474-1486.
35. Jee SH, Foong AW, Hur NW, Samet JM. Smoking 
and risk for diabetes incidence and mortality in Korean 
men and women. Diabetes Car. 2010; 33(12): 2567-2572.
36. Kim HC, Oh SM. Noncommunicable diseases: cur-
rent status of  major modifiable risk factors in Korea. 
Journal of  preventive medicine and public health. Ye-
bang Uihakhoe chi. 2013; 46 (4): 165-172.
37. Hur NW, Kim HC, Mo Nam C, Ha Jee S, Lee HC, 
Suh I. Smoking cessation and risk of  type 2 diabetes 
mellitus: Korea Medical Insurance Corporation Study. 
European Journal of  Cardiovascular Prevention & Rehabilita-
tion. 2007; 14(2): 244-249.
38. Hu G, Jousilahti P, Peltonen M, Lindström J, 
Tuomilehto J. Urinary sodium and potassium excretion 
and the risk of  type 2 diabetes: a prospective study in 
Finland. Diabetologia. 2005; 48(8): 1477-1483.
39. Ekinci EI, Cheong K, Dobson M, Premaratne E, 
Finch S, Macisaac RJ, Jerums G. High sodium and low 
potassium intake in patients with type 2 diabetes. Diabet-
ic Medicine. 2010; 27 (12): 1401-1408.
40. Ekinci EI, Clarke S, Thomas M.C, Moran JL, 
Cheong K, MacIsaac RJ, et al.. Dietary salt intake and 
mortality in patients with type 2 diabetes. Diabetes Care. 
2011; 34(3): 703-709.
41. Circulating cholesterol level and risk of  death from 
cancer in men aged 40 to 69 years. Experience of  an in-
ternational collaborative group. JAMA. 1982; 248(21): 
2853-2859.
42. Nomura AM, Stemmermann GN, Chyou P. Prospec-
tive study of  serum cholesterol levels and large-bowel 
cancer. JNCI: Journal of  the National Cancer Institute. 1991; 
83(19): 1403-1407.
43. Sorlie PD, Feinleib M. The serum cholesterol-can-
cer relationship: an analysis of  time trends in the Fram-
ingham Study. Journal of  the National Cancer Institute.1982; 
69(5): 989-996.
44. Williams RR, Sorlie PD, Feinleib M, McNamara PM, 
Kannel WB, Dawber TR. Cancer incidence by levels of  
cholesterol. JAMA.1981; 245(3): 247-252.
45. Motala AA, Esterhuizen T, Pirie FJ, Omar MA. The 
prevalence of  metabolic syndrome and determination 
of  the optimal waist circumference cutoff  points in a 
rural South African community. Diabetes Care. 2011 Feb 
14:DC_101921.
46. Tagoe DN, Amo-Kodieh P. Type 2 diabetes mellitus 
influences lipid profile of  diabetic patients. Annals of  
Biological Research. 2013; 4(6):88-92.
47. Sumner AE, Zhou J, Doumatey A, Imoisili OE, 
Amoah A, Acheampong J, Oli J, Johnson T, Ade-
bamowo C, Rotimi CN. Low HDL-cholesterol with 
normal triglyceride levels is the most common lipid 
pattern in West Africans and African Americans with 
metabolic syndrome: implications for cardiovascular 
disease prevention. CVD Prevention and Control. 2010 
Sep 1; 5(3):75-80.
48. Fagot-Campagna AN, Knowler WC, Narayan KM, 
Hanson RL, Saaddine J, Howard BV. HDL choles-
terol subfractions and risk of  developing type 2 dia-
betes among Pima Indians. Diabetes Care. 1999 Feb 1; 
22(2):271-4.
49. Njølstad I, Amesen E, Lund-Larsen PG. Sex dif-
ferences in risk factors for clinical diabetes mellitus in 
a general population: a 12-year follow-up of  the Finn-
mark Study. American Journal of  Epidemiology. 1998 Jan 1; 
147(1):49-58.
50. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, 
Patterson JK. Cardiovascular risk factors in confirmed 
prediabetic individuals: does the clock for coronary 
heart disease start ticking before the onset of  clinical 
diabetes?. JAMA. 1990 Jun 6; 263(21):2893-8.
51. Montonen J, Drogan D, Joost HG, Boeing H, 
Fritsche A, Schleicher E, Schulze MB, Pischon T. Esti-
mation of  the contribution of  biomarkers of  different 
metabolic pathways to risk of  type 2 diabetes. European 
Journal of  Epidemiology. 2011 Jan 1; 26(1):29-38.
52. Gordon T, Castelli WP, Hjortland MC, Kannel WB, 
Dawber TR. High density lipoprotein as a protective 
factor against coronary heart disease: the Framingham 
Study. The American Journal of  Medicine. 1977 May 1; 
62(5):707-14.
53. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, 
Castelli WP, Knoke JD, Jacobs Jr DR, Bangdiwala S, Ty-
roler HA. High-density lipoprotein cholesterol and car-
diovascular disease. Four prospective American studies. 
Circulation. 1989 Jan; 79(1):8-15.
54. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, 
Sorlie PD, Catellier D, Patsch W. Coronary heart disease 
prediction from lipoprotein cholesterol levels, triglyc-
erides, lipoprotein (a), apolipoproteins AI and B, and 
HDL density subfractions: The Atherosclerosis Risk 
African Health Sciences Vol 20 Issue 3, September, 20201353
in Communities (ARIC) Study. Circulation. 2001 Sep 4; 
104(10):1108-13.
55. Karadag F, Ozcan H, Karul AB, Yilmaz M, Cildag 
O. Sex hormone alterations and systemic inflammation 
in chronic obstructive pulmonary disease. International 
Journal of  Clinical Practice. 2009 Feb; 63(2):275-81.
56. Morton J, Zoungas S, Li Q, Patel AA, Chalmers 
J, Woodward M, Celermajer DS, Beulens JW, Stolk 
RP, Glasziou P, Ng MK. Low HDL cholesterol and 
the risk of  diabetic nephropathy and retinopathy: re-
sults of  the ADVANCE study. Diabetes Care. 2012 Aug 
10:DC_120306.
57. Kucharska-Newton AM, Rosamond WD, Schroed-
er JC, McNeill AM, Coresh J, Folsom AR. HDL-cho-
lesterol and the incidence of  lung cancer in the Ath-
erosclerosis Risk in Communities (ARIC) study. Lung 
Cancer. 2008 Sep 1; 61(3):292-300.
58. Filippatos TD, Elisaf  MS. High density lipoprotein 
and cardiovascular diseases. World Journal of  Cardiology. 
2013 Jul 26; 5(7):210.
59. Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R, 
Brown DW, Walke H. 2012, Prevalence of  selected 
chronic, noncommunicable disease risk factors in Jor-
dan: results of  the 2007 Jordan Behavioral Risk Factor 
Surveillance Survey. Preventing Chronic Disease. 2018; 9: 
E25.
60. Vasan RS, Beiser A, Seshadri S, Larson MG, Kan-
nel WB, D'agostino RB, Levy D. Residual lifetime risk 
for developing hypertension in middle-aged women 
and men: The Framingham Heart Study. JAMA.2002; 
287(8): 1003-1010.
61. Redon J, Cea-Calvo L, Moreno B, Monereo S, 
Gil-Guillen V, Lozano JV, et al. Independent impact of  
obesity and fat distribution in hypertension prevalence 
and control in the elderly. Journal of  Hypertension. 2008; 
26(9): 1757-1764.
62. Rudatsikira E, Muula AS, Mulenga D, Siziya S. Prev-
alence and correlates of  obesity among Lusaka resi-
dents, Zambia: a population-based survey. International 
Archives of  Medicine. 2012; 5(1): 14.
63. Mulenga D, Siziya S, Rudatsikira E, Mukonka V, Ba-
baniyi O, Songolo P, et al .District specific correlates for 
hypertension in Kaoma and Kasama rural districts of  
Zambia. Rural Remote Health.2013; 13(3): 2345.
64. Reddy S, Prabhu G. Prevalence and risk factors of  
hypertension in adults in an Urban Slum, Tirupati, AP. 
Indian Journal of  community medicine. 2005; 30(3): 84.
65. Dhungana RR, Pandey AR, Bista B, Joshi S, Devko-
ta S. Prevalence and associated factors of  hypertension: 
a community-based cross-sectional study in municipali-
ties of  Kathmandu, Nepal. International Journal of  Hyper-
tension, .2016: 2016.
66. Pandey A, Patni N, Sarangi S, Singh M, Sharma K, 
Vellimana A.K, et al. Association of  exclusive smoke-
less tobacco consumption with hypertension in an adult 
male rural population of  India. Tobacco induced diseases. 
2009; 5(1):15.
67. Shanthirani C, Pradeepa R, Deepa R, Premalatha 
G, Saroja R, Mohan V. Prevalence and risk factors of  
hypertension in a selected South Indian population--the 
Chennai Urban Population Study. The Journal of  the Asso-
ciation of  Physicians of  India. 2003; 51: 20-27.
68. SIngh RB, Fedacko J, Pella D, Macejova Z, Ghosh 
S, De AK, Begom R, et al. 2011, Prevalence and risk 
factors for prehypertension and hypertension in five 
Indian cities. Acta Cardiologica.2011; 66, no. 1, pp. 29-37.
69. Mohan V, Deepa M, Farooq S, Datta M, Deepa R. 
Prevalence, awareness and control of  hypertension in 
Chennai-the Chennai urban rural epidemiology study 
(CURES–52). Journal of  Association of  Physicians of  India. 
2007; 55: 326-332.
African Health Sciences Vol 20 Issue 3, September, 2020 1354
